Anidrase carbónica
A anidrase carbônica é uma enzima que catalisa a conversão reversível de dióxido de carbono e água em bicarbonato e prótons. Esta enzima desempenha um papel crucial na manutenção do equilíbrio ácido-base, respiração e transporte de dióxido de carbono no sangue. Inibidores da anidrase carbônica são usados no tratamento de glaucoma, epilepsia e mal da altitude, bem como em pesquisas sobre homeostase ácido-base e troca gasosa. Na CymitQuimica, oferecemos uma gama de inibidores e reagentes de anidrase carbônica de alta qualidade para apoiar sua pesquisa em enzimologia, fisiologia respiratória e desenvolvimento terapêutico.
Foram encontrados 178 produtos de "Anidrase carbónica"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
hCAXII-IN-5
CAS:<p>hCAXII-IN-5, or compound 6o, is a potent, selective hCAXII inhibitor with Ki values: hCAI & II >10000, hCAIX 286.1, hCAXII 1.0 nM.</p>Fórmula:C23H22N2O4Cor e Forma:SolidPeso molecular:390.43AHR-15010
CAS:<p>AHR-15010 is a novel anti-arthritic agent.</p>Fórmula:C10H16N2O8S2Pureza:98%Cor e Forma:SolidPeso molecular:356.37L-693612 HCl
CAS:<p>L-693612 HCl is an inhibitor of carbonic anhydrase.</p>Fórmula:C14H25ClN2O5S3Pureza:98%Cor e Forma:SolidPeso molecular:433.01hCAIX-IN-7
CAS:<p>hCAIX-IN-7 (6c) selectively inhibits tumor-related isoform hCAIX (KI: 410.6 nM) and weakly affects hCAI/II (KI: >10000 nM).</p>Fórmula:C18H12FNO3Cor e Forma:SolidPeso molecular:309.29Carbonic anhydrase inhibitor 13
CAS:<p>Carbonic anhydrase inhibitor 13 (compound 7) is a potent inhibitor of carbonic anhydrase (CA).</p>Fórmula:C17H15N5O3S2Cor e Forma:SolidPeso molecular:401.46hCAIX-IN-3
CAS:<p>hCAII-IN-3 (7e) selectively inhibits CA II/IX with Kis of 124.2/30.5 nM, showing promise for cancer treatment.</p>Fórmula:C21H21BrN6O4SCor e Forma:SolidPeso molecular:533.4hCAIX-IN-14
CAS:<p>hCAIX-IN-14 is a potent inhibitor of human CA IX with a K i value of 134.8 nM .</p>Fórmula:C11H17ClN6O2SCor e Forma:SolidPeso molecular:332.81Carbonic anhydrase inhibitor 7
CAS:<p>Potent hCA inhibitor; targets hCA IX, II, XII, I with Ki: 6.5, 7.1, 72.1, 255.8 nM respectively.</p>Fórmula:C23H17N3O5SCor e Forma:SolidPeso molecular:447.46hCAXII-IN-1
CAS:<p>hCAXII-IN-1 selectively inhibits HCA IX/XII, promising for new cancer drug development.</p>Fórmula:C20H17NO5Cor e Forma:SolidPeso molecular:351.35Quinethazone
CAS:<p>Quinethazone is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.</p>Fórmula:C10H12ClN3O3SCor e Forma:Fibrous Crystals From 50% Acetone Physical Description Fibrous Crystals Or White Powder (Ntp 1992)Peso molecular:289.74hCAIX-IN-10
CAS:<p>"hCAIX-IN-10 (6i) selectively inhibits carbonic anhydrase IX/XII (Ki: 61.5/586.8 nM), markers in tumor cells, affecting acid-base balance."</p>Fórmula:C28H21N3O3SCor e Forma:SolidPeso molecular:479.55hCAIX-IN-6
CAS:<p>6B and 14g inhibit tumor-associated HCA IX with low nanomolar potency; 6K targets HCA XII. All are potential cancer drug leads.</p>Fórmula:C18H12N2O4SCor e Forma:SolidPeso molecular:352.36DTP348
CAS:<p>DTP348: Oral carbonic anhydrase IX inhibitor & hypoxic cell radiosensitizer with sulfamide & 5-nitroimidazole components.</p>Fórmula:C6H11N5O4SCor e Forma:SolidPeso molecular:249.25Carbonic anhydrase inhibitor 11
CAS:<p>Potent carbonic anhydrase inhibitor VI targets CA II, IX, XII with Ki: 40, 39, 900 nM respectively.</p>Fórmula:C19H15F3N4O3S2Cor e Forma:SolidPeso molecular:468.47hCAIX/XII-IN-4
CAS:<p>hCAIX/XII-IN-4 inhibits CAIX/XII with Ki: 4.5 nM (CAXII), 23.6 nM (CAIX), and >10000 nM (CAI/CAII).</p>Fórmula:C20H16N2O5Cor e Forma:SolidPeso molecular:364.35hCAXII-IN-4
CAS:<p>hCAXII-IN-4 is a selective and potent CA XII inhibitor with a Ki value of 6.4 nM for human CA XII.</p>Fórmula:C22H27N5O6SCor e Forma:SolidPeso molecular:489.54hCAI/II-IN-2
CAS:<p>hCAI/II-IN-2 (2b) inhibits hCA I/II (Ki: 40.97 nM, 15.15 nM) and IX (61.88 nM), fights AMS with anti-hypoxic effects, but has low cellular activity.</p>Fórmula:C12H12N4O5S2Cor e Forma:SolidPeso molecular:356.38hCA IX-IN-2
<p>hCA IX-IN-2 is a highly potent and selective inhibitor of hCA IX, exhibiting an inhibition constant (K I) value of 32.1 nM and demonstrating anti-proliferative</p>Fórmula:C23H24N2O4STeCor e Forma:SolidPeso molecular:552.11hCAI/II-IN-3
CAS:<p>"hCAI/II-IN-3 (compound 5b) is a potent dual hCA I/II inhibitor with Ki: 51.25nM (I), 13.15nM (II), helps treat AMS."</p>Fórmula:C16H18N4O4S2Cor e Forma:SolidPeso molecular:394.47hCAIX/XII-IN-6
<p>hCAIX/XII-IN-6: Oral carbonic anhydrase inhibitor, targets hCA I/II/IV/IX/XII, aids rheumatoid arthritis research. Ki: 6697/2950/4093/4.1/7.7 nM.</p>Fórmula:C26H23N3O6S4Cor e Forma:SolidPeso molecular:601.74
